AI DIAGNOSTIX
Enhancing Accuracy, Efficiency, and Patient Outcomes.
AI Diagnostix is a global healthcare technology company dedicated to leveraging the power of artificial intelligence to transform the field of radiology. Our cutting-edge software solution enhances the accuracy and efficiency of diagnostic processes, improving patient outcomes and empowering medical professionals.
NeuroDetect is a sophisticated brain MRI analysis software designed for the detailed detection, segmentation, and quantification of brain tumors. This tool empowers neuroradiologists and neuro-oncologists to obtain precise, quantitative data on brain anomalies, significantly aiding in the diagnosis, treatment planning, and monitoring of neurological conditions
NeuroOnco is an advanced MRI comparison tool specifically designed for oncology radiology. This innovative software solution is engineered to assist medical professionals in accurately assessing the progression or regression of tumors. Leveraging cutting-edge imaging technology, it offers detailed comparative analysis, enabling oncologists and radiologists to track tumor changes over time with precision
Our dedication to excellence drives us to constantly innovate and improve. At AI Diagnostix, we’re committed to setting new benchmarks in medical imaging, ensuring every solution we provide is of the highest quality, reliability, and efficiency.
"NeuroOnco has revolutionized our tumor monitoring process. The ability to precisely compare MRI scans over time has greatly enhanced our treatment planning and patient care. It's an indispensable part of our oncology department."
Adam "AI Diagnostix's solutions have significantly streamlined our imaging workflows, reducing wait times and increasing patient throughput. Their commitment to excellence and innovation is evident in the quality and reliability of their products."
EvaDEMO
Discover the transformative power of our specialized medical imaging solutions by scheduling a personalized demo today. Our expert team will guide you through the advanced capabilities of our products, NeuroOnco and NeuroDetect Segmentation Tool, demonstrating how they can address the specific challenges faced by your organization. Experience firsthand how our innovative software can optimize your workflow, enhance diagnostic accuracy, and ultimately improve patient outcomes. This one-on-one session is a unique opportunity to see our technology in action and discuss how it can be tailored to fit your unique operational needs.
AI Diagnostix is a global health tech company specializing in artificial intelligence solutions for medical imaging, focusing on enhancing the efficiency and accuracy of MRI scan analysis and reporting.
By leveraging AI technology, AI Diagnostix transforms the way MRI scans are analyzed and reported, speeding up the diagnostic process, reducing errors, and improving overall workflow efficiency in medical imaging.
Yes, we designed AI Diagnostix to be a plug-and-play solution, which makes installing it into your current workflow easy and manageable. AI Diagnostix software is its own standalone viewer due to the functionality we offer, such as segmentation, quantification, and analysis reporting.
NeuroDetect stands out for its sophisticated brain MRI analysis capabilities, providing detailed detection, segmentation, and quantification of brain tumors, thus offering invaluable support in neurological diagnostics and treatment planning.
NeuroOnco is an MRI comparison tool tailored for oncology radiology, enabling medical professionals to accurately track the progression or regression of tumors over time, enhancing the decision-making process in patient care.
AI Diagnostix commits to high standards through rigorous testing, continuous research and development, and adherence to international healthcare regulations, ensuring that our products are not only innovative but also reliable and effective in clinical environments.
AI Diagnostix is an innovative global healthcare company revolutionizing the medical imaging sector.
© 2024 AI Diagnostix. All rights reserved.
"Since integrating NeuroDetect into our practice, we've seen a remarkable improvement in the accuracy and speed of our brain tumor diagnoses. It's not just a tool; it's a game-changer for how we approach neurological imaging."
Peter Johns Head of informatics at EBI